422 related articles for article (PubMed ID: 29329555)
1. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Fairchild A; Courneya KS
Trials; 2018 Jan; 19(1):35. PubMed ID: 29329555
[TBL] [Abstract][Full Text] [Related]
2. Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial.
Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Joseph K; Nijjar T; Fairchild A; Courneya KS
Clin Colorectal Cancer; 2021 Sep; 20(3):216-226. PubMed ID: 34158253
[TBL] [Abstract][Full Text] [Related]
3. A Phase I Study Examining the Feasibility and Safety of an Aerobic Exercise Intervention in Patients With Rectal Cancer During and After Neoadjuvant Chemoradiotherapy.
Morielli AR; Usmani N; Boulé NG; Tankel K; Severin D; Nijjar T; Joseph K; Courneya KS
Oncol Nurs Forum; 2016 May; 43(3):352-62. PubMed ID: 27105196
[TBL] [Abstract][Full Text] [Related]
4. Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial.
Morielli AR; Boulé NG; Usmani N; Tankel K; Joseph K; Severin D; Fairchild A; Nijjar T; Courneya KS
J Cancer Surviv; 2023 Aug; 17(4):1171-1183. PubMed ID: 34841461
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and preliminary effectiveness of a physical exercise training program during neoadjuvant chemoradiotherapy in individual patients with rectal cancer prior to major elective surgery.
Heldens AF; Bongers BC; de Vos-Geelen J; van Meeteren NL; Lenssen AF
Eur J Surg Oncol; 2016 Sep; 42(9):1322-30. PubMed ID: 27156145
[TBL] [Abstract][Full Text] [Related]
6. Exercise motivation in rectal cancer patients during and after neoadjuvant chemoradiotherapy.
Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Courneya KS
Support Care Cancer; 2016 Jul; 24(7):2919-26. PubMed ID: 26847350
[TBL] [Abstract][Full Text] [Related]
7. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial.
Loughney L; West MA; Kemp GJ; Rossiter HB; Burke SM; Cox T; Barben CP; Mythen MG; Calverley P; Palmer DH; Grocott MP; Jack S
Trials; 2016 Jan; 17():24. PubMed ID: 26762365
[TBL] [Abstract][Full Text] [Related]
8. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
West MA; Astin R; Moyses HE; Cave J; White D; Levett DZH; Bates A; Brown G; Grocott MPW; Jack S
Acta Oncol; 2019 May; 58(5):588-595. PubMed ID: 30724668
[TBL] [Abstract][Full Text] [Related]
9. The effect of a pre- and post-operative exercise programme versus standard care on physical fitness of patients with oesophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (The PERIOP-OG Trial): Study protocol for a randomised controlled trial.
Tully R; Loughney L; Bolger J; Sorensen J; McAnena O; Collins CG; Carroll PA; Arumugasamy M; Murphy TJ; Robb WB;
Trials; 2020 Jul; 21(1):638. PubMed ID: 32660526
[TBL] [Abstract][Full Text] [Related]
10. Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study.
West MA; Loughney L; Lythgoe D; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
Br J Anaesth; 2015 Feb; 114(2):244-51. PubMed ID: 25274049
[TBL] [Abstract][Full Text] [Related]
11. The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients.
West MA; Loughney L; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
Eur J Surg Oncol; 2014 Nov; 40(11):1421-8. PubMed ID: 24784775
[TBL] [Abstract][Full Text] [Related]
12. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
13. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
14. Predictors of adherence to aerobic exercise in rectal cancer patients during and after neoadjuvant chemoradiotherapy.
Morielli AR; Boulé NG; Usmani N; Joseph K; Tankel K; Severin D; Courneya KS
Psychol Health Med; 2018 Feb; 23(2):224-231. PubMed ID: 28635312
[TBL] [Abstract][Full Text] [Related]
15. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
16. Prehabilitation is feasible in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy and may minimize physical deterioration: results from the REx trial.
Moug SJ; Mutrie N; Barry SJE; Mackay G; Steele RJC; Boachie C; Buchan C; Anderson AS
Colorectal Dis; 2019 May; 21(5):548-562. PubMed ID: 30657249
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
[TBL] [Abstract][Full Text] [Related]
18. The effect of neoadjuvant chemoradiotherapy on whole-body physical fitness and skeletal muscle mitochondrial oxidative phosphorylation in vivo in locally advanced rectal cancer patients--an observational pilot study.
West MA; Loughney L; Lythgoe D; Barben CP; Adams VL; Bimson WE; Grocott MP; Jack S; Kemp GJ
PLoS One; 2014; 9(12):e111526. PubMed ID: 25478898
[TBL] [Abstract][Full Text] [Related]
19. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
[TBL] [Abstract][Full Text] [Related]
20. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
Rullier E; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sileznieff I; Prudhomme M; Marchal F; Pocard M; Pezet D; Rullier A; Vendrely V; Denost Q; Asselineau J; Doussau A
Lancet; 2017 Jul; 390(10093):469-479. PubMed ID: 28601342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
